Prof. Dr. Başar Bilgiç was born in 1973 in Ankara, Turkey. In 1997, he completed his medical degree at Ankara University Faculty of Medicine. He received his neurology specialization at Istanbul University, Istanbul Faculty of Medicine in 2002. Between 2002 and 2004, he completed a fellowship in Behavioral Neurology and Movement Disorders. Since 2010, he has been working at Istanbul University, Faculty of Medicine, Behavioral Neurology and Movement Disorders Unit.

His main research areas are dementia, Alzheimer’s disease, and movement disorders. He has authored more than 250 scientific publications with over 9,500 citations. He is a member of the Turkish Neurological Society, Turkish Neuropsychiatric Society, and the American Academy of Neurology. He served as the President of the Turkish Alzheimer Association from 2021 to 2025, and currently holds the position of Head of the Medical Board.of the association. Prof. Bilgiç is recognized internationally for his contributions to neurodegenerative disease research.

In the year 2000, Dr Akbostancı was appointed as an associate professor at Ankara University Faculty of Medicine, where he established the Movement Disorders Unit in 1992.

He is currently a retired faculty member of Ankara University Faculty of Medicine Department of Neurology and Ankara University Rectorate Department of Neuroscience, who served as the head of the Movement Disorders Unit and director of the Ankara University Brain Research Research and Application Center.

For the past 24 years, he has been organizing the Botulinum Toxin Autumn Symposium regularly. He has written four textbooks on movement disorders. His international work can be accessed on PubMed with the keyword AKBOSTANCI. According to the Higher Education Council database (YÖKSİS), as of March 2025, he has written 290 scientific articles, five textbooks, and 14 book chapters, and his scientific activities have been supported nine times by research fund suppliers (TÜBİTAK, etc.).  In his clinical practice, he evaluates  patients with Parkinson’s Disease, dystonia, and other movement disorders.